Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 88 Pages
Report ld: 4611610
Request Sample
Customized Report
The global market for Human EGFR Gene Mutation Detection Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
North American market for Human EGFR Gene Mutation Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human EGFR Gene Mutation Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human EGFR Gene Mutation Detection Kit include Roche Diagnostics, QIAGEN, Revvity, DNA-Technology, 3B BlackBio Dx, DiaCarta, Amoy Diagnostics, BGI, Weizhen Biotech, Daan Gene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Human EGFR Gene Mutation Detection Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human EGFR Gene Mutation Detection Kit.
The Human EGFR Gene Mutation Detection Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human EGFR Gene Mutation Detection Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human EGFR Gene Mutation Detection Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche Diagnostics
QIAGEN
Revvity
DNA-Technology
3B BlackBio Dx
DiaCarta
Amoy Diagnostics
BGI
Weizhen Biotech
Daan Gene
Toujing Life Science
Yishan Biotech
Shenrui Biotech
Heshi Biotech
Segment by Type
Sequencing Method
Multiplex Fluorescence PCR Method
Digital PCR Method
Other
Segment by Application
Clinical
Scientific Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human EGFR Gene Mutation Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human EGFR Gene Mutation Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human EGFR Gene Mutation Detection Kit Market Overview
1.1 Product Definition
1.2 Human EGFR Gene Mutation Detection Kit by Type
1.2.1 Global Human EGFR Gene Mutation Detection Kit Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sequencing Method
1.2.3 Multiplex Fluorescence PCR Method
1.2.4 Digital PCR Method
1.2.5 Other
1.3 Human EGFR Gene Mutation Detection Kit by Application
1.3.1 Global Human EGFR Gene Mutation Detection Kit Market Value by Application (2024 VS 2031)
1.3.2 Clinical
1.3.3 Scientific Research
1.4 Global Human EGFR Gene Mutation Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Human EGFR Gene Mutation Detection Kit Revenue 2020-2031
1.4.2 Global Human EGFR Gene Mutation Detection Kit Sales 2020-2031
1.4.3 Global Human EGFR Gene Mutation Detection Kit Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human EGFR Gene Mutation Detection Kit Market Competition by Manufacturers
2.1 Global Human EGFR Gene Mutation Detection Kit Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human EGFR Gene Mutation Detection Kit Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human EGFR Gene Mutation Detection Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human EGFR Gene Mutation Detection Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human EGFR Gene Mutation Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human EGFR Gene Mutation Detection Kit, Product Type & Application
2.7 Global Key Manufacturers of Human EGFR Gene Mutation Detection Kit, Date of Enter into This Industry
2.8 Global Human EGFR Gene Mutation Detection Kit Market Competitive Situation and Trends
2.8.1 Global Human EGFR Gene Mutation Detection Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human EGFR Gene Mutation Detection Kit Players Market Share by Revenue
2.8.3 Global Human EGFR Gene Mutation Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human EGFR Gene Mutation Detection Kit Market Scenario by Region
3.1 Global Human EGFR Gene Mutation Detection Kit Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human EGFR Gene Mutation Detection Kit Sales by Region: 2020-2031
3.2.1 Global Human EGFR Gene Mutation Detection Kit Sales by Region: 2020-2025
3.2.2 Global Human EGFR Gene Mutation Detection Kit Sales by Region: 2026-2031
3.3 Global Human EGFR Gene Mutation Detection Kit Revenue by Region: 2020-2031
3.3.1 Global Human EGFR Gene Mutation Detection Kit Revenue by Region: 2020-2025
3.3.2 Global Human EGFR Gene Mutation Detection Kit Revenue by Region: 2026-2031
3.4 North America Human EGFR Gene Mutation Detection Kit Market Facts & Figures by Country
3.4.1 North America Human EGFR Gene Mutation Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human EGFR Gene Mutation Detection Kit Sales by Country (2020-2031)
3.4.3 North America Human EGFR Gene Mutation Detection Kit Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human EGFR Gene Mutation Detection Kit Market Facts & Figures by Country
3.5.1 Europe Human EGFR Gene Mutation Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human EGFR Gene Mutation Detection Kit Sales by Country (2020-2031)
3.5.3 Europe Human EGFR Gene Mutation Detection Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human EGFR Gene Mutation Detection Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Human EGFR Gene Mutation Detection Kit Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human EGFR Gene Mutation Detection Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific Human EGFR Gene Mutation Detection Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human EGFR Gene Mutation Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Human EGFR Gene Mutation Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human EGFR Gene Mutation Detection Kit Sales by Country (2020-2031)
3.7.3 Latin America Human EGFR Gene Mutation Detection Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human EGFR Gene Mutation Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Human EGFR Gene Mutation Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human EGFR Gene Mutation Detection Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human EGFR Gene Mutation Detection Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human EGFR Gene Mutation Detection Kit Sales by Type (2020-2031)
4.1.1 Global Human EGFR Gene Mutation Detection Kit Sales by Type (2020-2025)
4.1.2 Global Human EGFR Gene Mutation Detection Kit Sales by Type (2026-2031)
4.1.3 Global Human EGFR Gene Mutation Detection Kit Sales Market Share by Type (2020-2031)
4.2 Global Human EGFR Gene Mutation Detection Kit Revenue by Type (2020-2031)
4.2.1 Global Human EGFR Gene Mutation Detection Kit Revenue by Type (2020-2025)
4.2.2 Global Human EGFR Gene Mutation Detection Kit Revenue by Type (2026-2031)
4.2.3 Global Human EGFR Gene Mutation Detection Kit Revenue Market Share by Type (2020-2031)
4.3 Global Human EGFR Gene Mutation Detection Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human EGFR Gene Mutation Detection Kit Sales by Application (2020-2031)
5.1.1 Global Human EGFR Gene Mutation Detection Kit Sales by Application (2020-2025)
5.1.2 Global Human EGFR Gene Mutation Detection Kit Sales by Application (2026-2031)
5.1.3 Global Human EGFR Gene Mutation Detection Kit Sales Market Share by Application (2020-2031)
5.2 Global Human EGFR Gene Mutation Detection Kit Revenue by Application (2020-2031)
5.2.1 Global Human EGFR Gene Mutation Detection Kit Revenue by Application (2020-2025)
5.2.2 Global Human EGFR Gene Mutation Detection Kit Revenue by Application (2026-2031)
5.2.3 Global Human EGFR Gene Mutation Detection Kit Revenue Market Share by Application (2020-2031)
5.3 Global Human EGFR Gene Mutation Detection Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Diagnostics Human EGFR Gene Mutation Detection Kit Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 QIAGEN
6.2.1 QIAGEN Company Information
6.2.2 QIAGEN Description and Business Overview
6.2.3 QIAGEN Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 QIAGEN Human EGFR Gene Mutation Detection Kit Product Portfolio
6.2.5 QIAGEN Recent Developments/Updates
6.3 Revvity
6.3.1 Revvity Company Information
6.3.2 Revvity Description and Business Overview
6.3.3 Revvity Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Revvity Human EGFR Gene Mutation Detection Kit Product Portfolio
6.3.5 Revvity Recent Developments/Updates
6.4 DNA-Technology
6.4.1 DNA-Technology Company Information
6.4.2 DNA-Technology Description and Business Overview
6.4.3 DNA-Technology Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 DNA-Technology Human EGFR Gene Mutation Detection Kit Product Portfolio
6.4.5 DNA-Technology Recent Developments/Updates
6.5 3B BlackBio Dx
6.5.1 3B BlackBio Dx Company Information
6.5.2 3B BlackBio Dx Description and Business Overview
6.5.3 3B BlackBio Dx Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 3B BlackBio Dx Human EGFR Gene Mutation Detection Kit Product Portfolio
6.5.5 3B BlackBio Dx Recent Developments/Updates
6.6 DiaCarta
6.6.1 DiaCarta Company Information
6.6.2 DiaCarta Description and Business Overview
6.6.3 DiaCarta Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 DiaCarta Human EGFR Gene Mutation Detection Kit Product Portfolio
6.6.5 DiaCarta Recent Developments/Updates
6.7 Amoy Diagnostics
6.7.1 Amoy Diagnostics Company Information
6.7.2 Amoy Diagnostics Description and Business Overview
6.7.3 Amoy Diagnostics Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Amoy Diagnostics Human EGFR Gene Mutation Detection Kit Product Portfolio
6.7.5 Amoy Diagnostics Recent Developments/Updates
6.8 BGI
6.8.1 BGI Company Information
6.8.2 BGI Description and Business Overview
6.8.3 BGI Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BGI Human EGFR Gene Mutation Detection Kit Product Portfolio
6.8.5 BGI Recent Developments/Updates
6.9 Weizhen Biotech
6.9.1 Weizhen Biotech Company Information
6.9.2 Weizhen Biotech Description and Business Overview
6.9.3 Weizhen Biotech Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Weizhen Biotech Human EGFR Gene Mutation Detection Kit Product Portfolio
6.9.5 Weizhen Biotech Recent Developments/Updates
6.10 Daan Gene
6.10.1 Daan Gene Company Information
6.10.2 Daan Gene Description and Business Overview
6.10.3 Daan Gene Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Daan Gene Human EGFR Gene Mutation Detection Kit Product Portfolio
6.10.5 Daan Gene Recent Developments/Updates
6.11 Toujing Life Science
6.11.1 Toujing Life Science Company Information
6.11.2 Toujing Life Science Description and Business Overview
6.11.3 Toujing Life Science Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Toujing Life Science Human EGFR Gene Mutation Detection Kit Product Portfolio
6.11.5 Toujing Life Science Recent Developments/Updates
6.12 Yishan Biotech
6.12.1 Yishan Biotech Company Information
6.12.2 Yishan Biotech Description and Business Overview
6.12.3 Yishan Biotech Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Yishan Biotech Human EGFR Gene Mutation Detection Kit Product Portfolio
6.12.5 Yishan Biotech Recent Developments/Updates
6.13 Shenrui Biotech
6.13.1 Shenrui Biotech Company Information
6.13.2 Shenrui Biotech Description and Business Overview
6.13.3 Shenrui Biotech Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shenrui Biotech Human EGFR Gene Mutation Detection Kit Product Portfolio
6.13.5 Shenrui Biotech Recent Developments/Updates
6.14 Heshi Biotech
6.14.1 Heshi Biotech Company Information
6.14.2 Heshi Biotech Description and Business Overview
6.14.3 Heshi Biotech Human EGFR Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Heshi Biotech Human EGFR Gene Mutation Detection Kit Product Portfolio
6.14.5 Heshi Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human EGFR Gene Mutation Detection Kit Industry Chain Analysis
7.2 Human EGFR Gene Mutation Detection Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human EGFR Gene Mutation Detection Kit Production Mode & Process Analysis
7.4 Human EGFR Gene Mutation Detection Kit Sales and Marketing
7.4.1 Human EGFR Gene Mutation Detection Kit Sales Channels
7.4.2 Human EGFR Gene Mutation Detection Kit Distributors
7.5 Human EGFR Gene Mutation Detection Kit Customer Analysis
8 Human EGFR Gene Mutation Detection Kit Market Dynamics
8.1 Human EGFR Gene Mutation Detection Kit Industry Trends
8.2 Human EGFR Gene Mutation Detection Kit Market Drivers
8.3 Human EGFR Gene Mutation Detection Kit Market Challenges
8.4 Human EGFR Gene Mutation Detection Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human EGFR Gene Mutation Detection Kit market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 156
USD 4900.00
(Single User License)
The global Human EGFR Gene Mutation Detection Kit market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 93
USD 4250.00
(Single User License)
The global market for Human EGFR Gene Mutation Detection Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 114
USD 3950.00
(Single User License)
The global Human EGFR Gene Mutation Detection Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 120
USD 2900.00
(Single User License)
The global Human EGFR Gene Mutation Detection Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 160
USD 4900.00
(Single User License)
The global Human EGFR Gene Mutation Detection Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 97
USD 4250.00
(Single User License)
The global market for Human EGFR Gene Mutation Detection Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 128
USD 3950.00
(Single User License)
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published Date: 2024-09-01
Pages: 128
USD 4350.00
(Single User License)
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published Date: 2024-09-01
Pages: 160
USD 4900.00
(Single User License)
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published Date: 2024-09-01
Pages: 93
USD 2900.00
(Single User License)
The global Human EGFR Gene Mutation Detection Kit market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 156
The global Human EGFR Gene Mutation Detection Kit market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 93
The global market for Human EGFR Gene Mutation Detection Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 114
The global Human EGFR Gene Mutation Detection Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 120
The global Human EGFR Gene Mutation Detection Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 160
The global Human EGFR Gene Mutation Detection Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 97
The global market for Human EGFR Gene Mutation Detection Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 128
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published: 2024-09-01
Pages: 128
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published: 2024-09-01
Pages: 160
Epidermal growth factor receptor (EGFR) is a membrane protein with an intracellular receptor tyrosine kinase (TK) on the surface of epidermal cells. EGFR plays a central role in transmitting signals that promote cell growth, survival, and proliferation by activating multiple downstream pathways, including the Ras-Raf-MAPK pathway, the PI3-kinase-PDK1-Akt pathway, and the JAK1/2-STAT pathway. EGFR overexpression and oncogenic mutations that constitutively activate the TK domain of EGFR have been found in various solid tumors, including lung and colorectal cancers.
Published: 2024-09-01
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now